SaveHealth reports on advancements in dementia medications, highlighting new treatments that modify disease progression and improve patient quality of life.
Key Takeaways An Alzheimer’s disease pill might help kids with autismMemantine boosted social functioning among these kids ...
The drug may slow the progression of Alzheimer’s disease, but it doesn’t improve the symptoms. It’s also incredibly expensive ...
Every few weeks, a 65-year-old man named Rick drives an hour and a half from his home in New Hampshire to Brigham and Women’s ...
More than a decade ago, scientist Tony Wyss-Coray stitched together the blood vessels of two mice, allowing their blood to ...
U.S. health experts this week will decide whether to recommend approval for Biogen Inc's Alzheimer's drug, which could become the first new treatment for the mind-wasting disease in decades even as ...
A large-scale study conducted on 92,383 adults observed over 28 years found that daily consumption of 7 grams of this oil lowered the risk of dementia-related death by 28%. Scientists are claiming ...
Scientists have found that a protein tied to Alzheimer’s disease may actually strengthen the immune system’s fight against ...
Alzheimer's disease (AD) is a neurodegenerative condition that typically affects older people and is the leading cause of dementia worldwide. AD is characterized by progressive cognitive impairment ...
Hameroff points to studies that demonstrate that, in humans, applying sub-thermal tFUS to the hippocampus of Alzheimer’s ...
ALTO-101 is an investigational phosphodiesterase-4 (PDE4) inhibitor delivered via a transdermal patch. Inhibition of the PDE4 enzyme is expected to enhance neural circuits and improve cognitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback